These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 24189469)

  • 1. Pancreatic cancer: standing on the shoulders of mice, making an iMPACT on pancreatic cancer.
    Villanueva MT
    Nat Rev Clin Oncol; 2013 Dec; 10(12):665. PubMed ID: 24189469
    [No Abstract]   [Full Text] [Related]  

  • 2. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Saltz LB; Bach PB
    N Engl J Med; 2014 Jan; 370(5):478. PubMed ID: 24476439
    [No Abstract]   [Full Text] [Related]  

  • 3. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Sahoo RK; Kumar L
    N Engl J Med; 2014 Jan; 370(5):478-9. PubMed ID: 24476440
    [No Abstract]   [Full Text] [Related]  

  • 4. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Von Hoff DD; Goldstein D; Renschler MF
    N Engl J Med; 2014 Jan; 370(5):479-80. PubMed ID: 24476438
    [No Abstract]   [Full Text] [Related]  

  • 5. New option for the initial management of metastatic pancreatic cancer?
    Abbruzzese JL; Hess KR
    J Clin Oncol; 2014 Aug; 32(23):2405-7. PubMed ID: 24982449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nab-paclitaxel use in pancreatic cancer: practical aspects and consequences in a French oncology day-care unit].
    Hubault M; Faure R; Walter T; Forestier J; Lombard-Bohas C; Pivot C
    Bull Cancer; 2015 May; 102(5):403-4. PubMed ID: 25866372
    [No Abstract]   [Full Text] [Related]  

  • 7. The winning formulation: the development of paclitaxel in pancreatic cancer.
    Ma WW; Hidalgo M
    Clin Cancer Res; 2013 Oct; 19(20):5572-9. PubMed ID: 23918602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Gemcitabine and Nab-Paclitaxel Misses the Target in Pancreas Adenocarcinoma: Or Did an Effective Therapy Fall to the Definition of Recurrence?
    Manji GA
    J Clin Oncol; 2023 Apr; 41(11):1972-1975. PubMed ID: 36854094
    [No Abstract]   [Full Text] [Related]  

  • 9. New therapeutic strategies in the second line setting of advanced or metastatic pancreatic adenocarcinoma.
    Ramfidis VS; Syrigos KN; Saif MW
    JOP; 2013 Jul; 14(4):344-6. PubMed ID: 23846924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Masses in a Patient With Pancreatic Adenocarcinoma and a History of Breast Carcinoma.
    Nunnery S; Bottinor W; Das S
    JAMA Oncol; 2020 Jun; 6(6):917-918. PubMed ID: 32324203
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
    Miwa H; Sugimori K; Ishii T; Funaoka A; Tsuchiya H; Suzuki Y; Sugimori M; Nishimura M; Tozuka Y; Komiyama S; Sato T; Kaneko T; Numata K; Maeda S
    Intern Med; 2021 Aug; 60(16):2607-2612. PubMed ID: 33642489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [nab-Paclitaxel as new therapeutic option for pancreatic cancer].
    Michl P
    Z Gastroenterol; 2013 Nov; 51(11):1329-30. PubMed ID: 24243574
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.
    Masuda S; Koizumi K; Moriya H; Nishino T; Uojima H; Tazawa T; Kimura K; Tasaki J; Ichita C; Sasaki A; Kako M; Hidaka S; Kudo M
    Intern Med; 2021 Jan; 60(2):251-257. PubMed ID: 32963158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting B cells in pancreatic adenocarcinoma: does RESOLVE resolve the question?
    Philip PA
    Ann Oncol; 2021 May; 32(5):582-583. PubMed ID: 33607222
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.
    Alvarez R; Musteanu M; Garcia-Garcia E; Lopez-Casas PP; Megias D; Guerra C; Muñoz M; Quijano Y; Cubillo A; Rodriguez-Pascual J; Plaza C; de Vicente E; Prados S; Tabernero S; Barbacid M; Lopez-Rios F; Hidalgo M
    Br J Cancer; 2014 Oct; 111(8):1677-8. PubMed ID: 24642623
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult.
    Boeck S; Haas M; Ormanns S; Kruger S; Siveke JT; Heinemann V
    Br J Cancer; 2014 Oct; 111(8):1675-6. PubMed ID: 24642615
    [No Abstract]   [Full Text] [Related]  

  • 17. Stellate cells, a point of light in the dark night of pancreatic cancer.
    Ramírez N; Viúdez A; Hernández-García I; Guerrero D; Gómez-Dorronsoro M; Herrera FJ; Vila J; Beloki L; Ciaúrriz M; Mansilla C; Vera R
    Br J Cancer; 2014 Oct; 111(8):1676-7. PubMed ID: 24642614
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic cancer: CONKO conquers.
    Villanueva MT
    Nat Rev Clin Oncol; 2014 Aug; 11(8):441. PubMed ID: 25027593
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cutting edge of chemotherapy for advanced pancreatic cancer].
    Kobayashi S; Ueno M; Furuse J
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(8):629-638. PubMed ID: 37558408
    [No Abstract]   [Full Text] [Related]  

  • 20. From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer.
    Seo YD; Wargo JA
    Cell Rep Med; 2023 May; 4(5):101039. PubMed ID: 37196631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.